Fairfield, Bush & Co. Abb Vie Inc. Transaction History

Fairfield, Bush & Co.

$168 Billion
Q3 2024

A detailed history of Fairfield, Bush & Co. transactions in Abb Vie Inc. stock. As of the latest transaction made, Fairfield, Bush & Co. holds 3,510 shares of ABBV stock, worth $595,401. This represents 0.41% of its overall portfolio holdings.

Number of Shares

3,510

Previous 3,175 10.55%

Holding current value

$595,401

Previous $545 Million 27.28%

% of portfolio

0.41%

Previous 0.33%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$163.84 - $199.33 $54,886 - $66,775	335 Added 10.55%	3,510 $693 Million
Q2 2024 Aug 15, 2024	SELL	$154.79 - $180.76 $145,966 - $170,456	-943 Reduced 22.9%	3,175 $545 Million
Q1 2024 May 15, 2024	SELL	$159.82 - $182.1 $123,540 - $140,763	-773 Reduced 15.8%	4,118 $750 Million
Q4 2023 Feb 13, 2024	SELL	$137.6 - $154.97 $53,388 - $60,128	-388 Reduced 7.35%	4,891 $758 Million
Q3 2023 Nov 15, 2023	SELL	$133.59 - $154.65 $26,450 - $30,620	-198 Reduced 3.62%	5,279 $787 Million
Q2 2023 Aug 15, 2023	SELL	$132.51 - $164.9 $29,417 - $36,607	-222 Reduced 3.9%	5,477 $738 Million
Q1 2023 May 15, 2023	SELL	$144.61 - $166.54 $133,475 - $153,716	-923 Reduced 13.94%	5,699 $908 Million
Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $6,638 - $7,961	-48 Reduced 0.72%	6,622 $1.07 Billion
Q3 2022 Nov 07, 2022	BUY	$134.21 - $153.93 $111,931 - $128,377	834 Added 14.29%	6,670 $895,000
Q2 2022 Aug 09, 2022	SELL	$137.62 - $174.96 $394,694 - $501,785	-2,868 Reduced 32.95%	5,836 $894,000
Q1 2022 May 06, 2022	SELL	$131.98 - $163.75 $88,030 - $109,221	-667 Reduced 7.12%	8,704 $1.41 Million
Q4 2021 Feb 09, 2022	BUY	$107.43 - $135.93 $104,421 - $132,123	972 Added 11.57%	9,371 $1.27 Million
Q3 2021 Nov 08, 2021	BUY	$106.4 - $120.78 $259,084 - $294,099	2,435 Added 40.83%	8,399 $906,000
Q2 2021 Aug 02, 2021	BUY	$105.21 - $117.21 $42,084 - $46,884	400 Added 7.19%	5,964 $671,000
Q1 2021 May 14, 2021	SELL	$102.3 - $112.62 $51,252 - $56,422	-501 Reduced 8.26%	5,564 $602,000
Q4 2020 Feb 12, 2021	SELL	$80.49 - $108.67 $317,130 - $428,159	-3,940 Closed	0 $0
Q3 2020 Nov 18, 2020	BUY	$85.91 - $100.83 $338,485 - $397,270	3,940 New	3,940 $345,000
Q2 2018 Aug 16, 2018	SELL	$89.78 - $106.23 $138,261 - $163,594	-1,540 Closed	0 $0
Q1 2018 May 09, 2018	BUY	$92.01 - $123.21 $141,695 - $189,743	1,540 New	1,540 $146,000

Others Institutions Holding ABBV

# of Institutions

3,837

Shares Held

1.25B

Call Options Held

15.7M

Put Options Held

11.3M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $300B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fairfield, Bush & Co., based on Form 13F filings with the SEC.

News

Stay updated on Fairfield, Bush & Co. with notifications on news.

Account

Fairfield, Bush & Co. Abb Vie Inc. Transaction History